Earnings Call · Q2 FY2021·2021-08-16

Q2 21EPS +28.57%·Rev n/aQ1 21EPS 0.00%·Rev n/aQ4 20EPS -23.08%·Rev n/aQ3 20EPS -24.00%·Rev n/a⚠ consensus missing

Eton Pharmaceuticals, Inc. ETON

David Krempa — Unknown

Sean Brynjelsen — Chief Executive Officer

Wilson Troutman — Chief Financial Officer

−4.1%1d on move date−4.3% vs SPY3d−1.1%5d−0.2%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ETON calls or request research access.

More ETON calls Browse calls Request research access